Coya Therapeutics Inc.

AI Score

0

Unlock

7.64
0.56 (7.91%)
At close: Mar 03, 2025, 3:59 PM
7.40
-3.14%
After-hours: Mar 03, 2025, 04:00 PM EST

Coya Therapeutics Income Statement

Year FY23 FY22 FY21 FY20
Revenue 6M n/a n/a n/a
Cost of Revenue 27.36K 27.36K 16.13K n/a
Gross Profit 5.97M -27.36K -16.13K n/a
Operating Income -7.9M -9.81M -4.87M -694.77K
Interest Income n/a n/a n/a 58.46
Pretax Income -7.26M -12.24M -4.89M -733.2K
Net Income -7.99M -14.68M -4.87M -733.2K
Selling & General & Admin 7.83M 4.85M 2.31M 445.8K
Research & Development 6.04M 4.94M 2.54M 248.97K
Other Expenses n/a 27.36K 16.13K n/a
Operating Expenses 13.91M 9.81M 4.87M 694.77K
Interest Expense n/a 2.43M n/a 38.98K
Selling & Marketing Expenses n/a n/a n/a 445.13K
Cost & Expenses 13.91M 9.81M 4.87M 694.77K
Income Tax 723.85K 2.43M -21.48K -704.65
Shares Outstanding (Basic) 10.16M 9.95M 9.68M 9.68M
Shares Outstanding (Diluted) 10.16M 9.95M 9.68M 9.68M
EPS (Basic) -0.79 -1.48 -0.5 -0.08
EPS (Diluted) -0.79 -1.48 -0.5 -0.08
EBITDA -7.88M -12.22M -4.85M 10.44K
Depreciation & Amortization 27.36K 27.36K 16.13K 704.65K